Girls in Colombian town struck by mystery illness

by Joshua Goodman

A mystery illness has overwhelmed a small town in northern Colombia as scores of teenage girls have been hospitalized with symptoms that parents fear could be an adverse reaction to a popular vaccine against cervical cancer.

Authorities say they still don't know what caused more than 200 girls in El Carmen de Bolivar to come down with symptoms ranging from fainting to numbness in the hands and headaches. Some have hinted that the town of 95,000 near Colombia's Caribbean coast could be experiencing a rare case of .

Parents are on edge however because all the girls, ranging in ages from 9 to 16, were injected in recent months with the Gardasil. On Wednesday, residents marched peacefully to demand a thorough investigation.

Francisco Vega, the town's mayor and a trained physician, told The Associated Press that illnesses first appeared at the end of May and have been steadily increasing since. Over the weekend 120 were rushed to hospitals, collapsing the town's limited medical facilities. None of their symptoms were life-threatening and all have since been released, he said.

Echoing the assurances of national health and toxicology experts, who have traveled to the town to collect blood samples and investigate possible environmental hazards, he said there's no evidence the vaccine, which has undergone extensive testing and regulation globally, is to blame.

Meanwhile, Health Minister Alejandro Gaviria is criticizing hyped coverage by the media for stirring panic, saying concerns about their vaccine, which has been applied to 2.9 million women in Colombia, are baseless.

"On one side we have the weight of scientific evidence and on the other are opinions and moral prejudices," he told W Radio on Wednesday, adding the claims the lives of more than 3,000 women every year in Colombia.

Veronica Trulin, head of communications in Latin America for Merck, said all lots of the vaccine, including the ones sent to Colombia, meet all required quality and safety standards.

"We don't comment on speculation about our products," she said in an email.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Teen HPV vaccination rate still lagging

Jul 25, 2013

(AP)—Disappointed health officials say only about half of teenage girls have gotten a controversial vaccine against cervical cancer—a rate that's changed little in three years.

1 in 5 boys got HPV shot in first year recommended

Aug 29, 2013

A new report offers a first look at how many boys are getting shots designed to protect girls from cervical cancer. Health officials say the number getting vaccinated so far is a good start.

Men's immunity could be key to new malaria drugs

Mar 12, 2014

(Medical Xpress)—A University of Alberta researcher's discovery about how malaria affects men could mean the difference between life and death for pregnant women in Colombia.

Three doses of HPV vaccine recommended against genital warts

Feb 11, 2014

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

Recommended for you

US warns Ebola could infect 1.4 million by 2015

1 hour ago

The number of Ebola infections in Liberia and Sierra Leone could skyrocket to 1.4 million by January 2015, according to a worst-case scenario released by US health authorities Tuesday.

Team finds method for more precise diagnosis of pneumonia

2 hours ago

A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia. It's a scenario well-known to physicians, ...

Screen women for chlamydia, gonorrhea, experts say

3 hours ago

(HealthDay)—All sexually active women should be screened for two of the most common sexually transmitted infections: chlamydia and gonorrhea, according to new recommendations from the U.S. Preventive Services ...

Noninvasive devices may help migraines, FDA says

4 hours ago

(HealthDay)—Two new prescription devices approved by the U.S. Food and Drug Administration (FDA) may provide some relief for people with migraine headaches who don't tolerate migraine medications well, ...

User comments